摘要
中药新药的注册申报涉及多种情况,其中中药经典名方、中药注射剂、中西药复方制剂等方面均为注册申报或中药监管所关注的热点或难点。重点比较了中国香港特别行政区中成药注册中固有药类别(古方)与中国内地经典名方(目前属于中药新药注册分类6.1类)注册申报的技术性资料要求的异同,同时对中药注射剂和中西药复方制剂不同的注册分类情况进行了对比。
The registration and application of new traditional Chinese medicine(TCM) involves a variety of situations, among which the TCM classical prescription, Chinese medicine injection, Chinese and western medicine compound preparation and other aspects are all the hot spots or difficulties in the registration and application or the supervision of TCM. This paper focuses on the comparison of the technical data requirements of the registration and application of the established medicines category(ancient prescription) in Hong Kong and the classic prescription in mainland of China(currently belonging to the new drug registration category 6.1 of TCM). At the same time, the registration classification of TCM injection and Chinese and western medicine compound preparation was compared.
作者
孙昱
SUN Yu(Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China)
出处
《药物评价研究》
CAS
2019年第8期1503-1508,共6页
Drug Evaluation Research
关键词
中药注册
古方
经典名方
中药注射剂
中西药复方制剂
registration of traditional Chinese medicine
ancient prescription
classical prescription
Chinese medicine injection
Chinese and western medicine compound preparation